ALK to present at the Jefferies Global Healthcare Conference in London

GlobeNewswire11-16

ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced that the company’s president & CEO, Peter Halling, is scheduled to participate in a fireside chat at the Jefferies Global Healthcare Conference in London taking place from 16 - 19 November 2026 on Wednesday, 18 November 2026, at 10.00 AM GMT / 11.00 AM CET.

A live webcast of the fireside chat will be accessible through this link and available on ALK’s investor site: Investors | ALK, where a recording of the webcast will also be archived after the event.

Representatives of the company will be available for meetings at the conference.

ALK-Abelló A/S

For further information, please contact:

Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525

Media: Maiken Riise Andersen, tel. +45 5054 1434

About ALK
ALK is a global specialty pharmaceutical company focused on allergy. ALK's activities cover the entire value chain of developing, sourcing, producing, and marketing a diversified portfolio of products for diagnosing and treating respiratory allergies and severe allergic reactions (anaphylaxis) in both children and adults.  Headquartered in Denmark, ALK employs around 2,800 people worldwide and is listed on Nasdaq Copenhagen (Nasdaq: ALK B). Visit us at www.alk.net.

Attachment

  • InvestorNews_16November26_Jefferies Global Healthcare Coference

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment